Indications:
- Treatment for 4 to 12 weeks of symptomatic, documented gastroesophageal reflux in adults who fail to respond to conventional therapy
- Relief of symptoms in adults with acute and recurrent diabetic gastroparesis
Please see full Prescribing Information for more information.